{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:48:34Z","timestamp":1792889314486,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015691","name":"NIAID DMID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017900","name":"United Malacca Berhad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["HHSN272201300022I"],"award-info":[{"award-number":["HHSN272201300022I"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["2R44AI058375"],"award-info":[{"award-number":["2R44AI058375"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015015","name":"Government of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006370","name":"Small Business Innovation Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.eclinm.2022.101579","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T07:06:34Z","timestamp":1659164794000},"page":"101579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial"],"prefix":"10.1016","volume":"52","author":[{"given":"Drissa","family":"Coulibaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoulaye K.","family":"Kone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Traore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amadou","family":"Niangaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bourema","family":"Kouriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-6533","authenticated-orcid":false,"given":"Charles","family":"Arama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amatigue","family":"Zeguime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amagana","family":"Dolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten E.","family":"Lyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher V.","family":"Plowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail E.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie K.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley M.","family":"Galbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effie","family":"Nomicos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Deye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Richie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"KC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Kim Lee","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogobara K.","family":"Doumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2679-035X","authenticated-orcid":false,"given":"Mahamadou A.","family":"Thera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Laurens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eclinm.2022.101579_bib0001","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/cid\/ciu954","article-title":"Vaccines against malaria","volume":"60","author":"Ouattara","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101579_bib0002","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/339409","article-title":"Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites","volume":"185","author":"Hoffman","year":"2002","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101579_bib0003","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa0805832","article-title":"Protection against a malaria challenge by sporozoite inoculation","volume":"361","author":"Roestenberg","year":"2009","journal-title":"N Engl J Med"},{"issue":"9779","key":"10.1016\/j.eclinm.2022.101579_bib0004","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0140-6736(11)60360-7","article-title":"Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study","volume":"377","author":"Roestenberg","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101579_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009594","article-title":"PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: a randomized, placebo-controlled trial with controlled human malaria infection","volume":"17","author":"Murphy","year":"2021","journal-title":"PLoS Pathog"},{"issue":"7642","key":"10.1016\/j.eclinm.2022.101579_bib0006","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature21060","article-title":"Sterile protection against human malaria by chemoattenuated PfSPZ vaccine","volume":"542","author":"Mordmuller","year":"2017","journal-title":"Nature"},{"issue":"6152","key":"10.1016\/j.eclinm.2022.101579_bib0007","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"},{"issue":"7866","key":"10.1016\/j.eclinm.2022.101579_bib0008","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-021-03684-z","article-title":"Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity","volume":"595","author":"Mwakingwe-Omari","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.eclinm.2022.101579_bib0009","doi-asserted-by":"crossref","unstructured":"Silva JC, Dwivedi A, Moser KA, et al. Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa. Nat Commun. 13(1), 2022, 3390.","DOI":"10.1038\/s41467-022-30882-8"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101579_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1086\/430707","article-title":"Community permission for medical research in developing countries","volume":"41","author":"Diallo","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.eclinm.2022.101579_bib0011","doi-asserted-by":"crossref","first-page":"e13490","DOI":"10.1371\/journal.pone.0013490","article-title":"Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trial","volume":"5","author":"Lyke","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2022.101579_bib0012","first-page":"1","article-title":"The natural duration of cancer","volume":"33","author":"Greenwood","year":"1926","journal-title":"Reports on Public Health and Medical Subjects"},{"issue":"53","key":"10.1016\/j.eclinm.2022.101579_bib0013","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","author":"Kaplan","year":"1958","journal-title":"J Am Statist Assoc"},{"key":"10.1016\/j.eclinm.2022.101579_bib0014","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12936-015-0628-0","article-title":"Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres","volume":"14","author":"Mordmuller","year":"2015","journal-title":"Malar J"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101579_bib0015","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1038\/s41467-021-22740-w","article-title":"Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial","volume":"12","author":"Sulyok","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101579_bib0016","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/CMR.00025-08","article-title":"Acquired immunity to malaria","volume":"22","author":"Doolan","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"6055","key":"10.1016\/j.eclinm.2022.101579_bib0017","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.1211548","article-title":"Live attenuated malaria vaccine designed to protect through hepatic CD8(+) T cell immunity","volume":"334","author":"Epstein","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101579_bib0018","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4269\/ajtmh.17-1014","article-title":"Safety, immunogenicity, and protective efficacy against controlled human malaria infection of Plasmodium falciparum sporozoite vaccine in Tanzanian adults","volume":"99","author":"Jongo","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101579_bib0019","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4269\/ajtmh.18-0835","article-title":"Safety and differential antibody and T-cell responses to the Plasmodium falciparum sporozoite malaria vaccine, PfSPZ vaccine, by age in Tanzanian adults, adolescents, children, and infants","volume":"100","author":"Jongo","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.eclinm.2022.101579_bib0020","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1093\/cid\/ciz1152","article-title":"Increase of dose associated with decrease in protection against controlled human malaria infection by PfSPZ vaccine in Tanzanian adults","volume":"71","author":"Jongo","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101579_bib0021","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1473-3099(21)00332-7","article-title":"Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial","volume":"22","author":"Sissoko","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101579_bib0022","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(17)30104-4","article-title":"Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial","volume":"17","author":"Sissoko","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.eclinm.2022.101579_bib0023","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-021-01470-y","article-title":"Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"27","author":"Oneko","year":"2021","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.eclinm.2022.101579_bib0024","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/infdis\/jiu293","article-title":"Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites","volume":"210","author":"Bijker","year":"2014","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101579_bib0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/infdis\/153.4.763","article-title":"Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum","volume":"153","author":"Ho","year":"1986","journal-title":"J Infect Dis"},{"issue":"56","key":"10.1016\/j.eclinm.2022.101579_bib0026","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0035-9203(62)90005-6","article-title":"Antibody response to tetanus toxoid inoculation in malarious and non-malarious Gambian children","author":"McGregor","year":"1962","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8078","key":"10.1016\/j.eclinm.2022.101579_bib0027","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(78)92403-0","article-title":"Impairment of the immune response to vaccination after acute malaria","volume":"1","author":"Williamson","year":"1978","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.eclinm.2022.101579_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CVI.00057-17","article-title":"Loss of humoral and cellular immunity to invasive nontyphoidal Salmonella during current or convalescent Plasmodium falciparum infection in Malawian children","volume":"24","author":"Nyirenda","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101579_bib0029","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/infdis\/jiv088","article-title":"Asymptomatic multiclonal Plasmodium falciparum infections carried through the dry season predict protection against subsequent clinical malaria","volume":"212","author":"Sonden","year":"2015","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101579_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170948","article-title":"High Plasmodium falciparum longitudinal prevalence is associated with high multiclonality and reduced clinical malaria risk in a seasonal transmission area of Mali","volume":"12","author":"Adomako-Ankomah","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101579_bib0031","first-page":"1","article-title":"Plasmodium berghei: suppression of antibody response to sporozoite stage by acute blood stage infection","volume":"38","author":"Orjih","year":"1979","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101579_bib0032","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.20021072","article-title":"Malaria blood stage suppression of liver stage immunity by dendritic cells","volume":"197","author":"Ocana-Morgner","year":"2003","journal-title":"J Exp Med"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022003091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022003091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:13:30Z","timestamp":1762888410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537022003091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"alternative-id":["S2589537022003091"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101579","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101579"}}